← 產業報告目錄

Cochlear Implants Market by Component Type (Cochlear Implants, Upgrades & Accessories), Type of Implants (Unilateral, Bilateral), Patient Type (Adults, Pediatrics), End User (Hospitals, ENT Clinics) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-02-07頁數 216報告編號 MD9284

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global cochlear implants market is valued at an estimated 2.80 billion in 2024 and is projected to reach USD 4.73 billion by 2030, at a CAGR of 9.2% during the forecast period. With the global increase in aging populations, age-related hearing loss (presbycusis) is becoming more common, creating a larger pool of potential candidates for cochlear implantation. WHO-reported data suggests that over 1.5 billion people-just under 20% of the global population-with hearing loss existed, of which around 430 million have disabling hearing loss, and are expected to rise by more than double-750 million in 2050. The main driver of these growth factors, the rising incidence of hearing problems, fuels further demand for CI. In 2023, the pediatric segment accounted for the largest share of the cochlear implants market, by patient type. Adults and pediatrics make up the patient type-based segments of the cochlear implants market. Market share for cochlear implants was highest in the peadiatrics in 2023. This is mainly due to the high incidence of hearing loss in children, increasing technological advancements, early diagnosis of hearing impairments through newborn screening programs, and growing awareness among parents about the benefits of early intervention. “The hospitals segment is projected to witness the highest growth rate in the cochlear implants market, by end user, during the forecast period.” Based on end user, the cochlear implants market is segmented into hospitals, ENT clinics, and other end users. The driving factors that force hospitals to adopt cochlear implants include better patient outcomes, a multidisciplinary team approach, and novel surgical technologies. Besides, investment in hospital infrastructure-especially within emerging markets-and insurance cover for cochlear implants ensure better access and, consequently, better affordability of cochlear implants, increasing their demand in the hospital environment. “The Asia Pacific region is projected to witness highest growth rate in the cochlear implants market during the forecast period” The global cochlear implants market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the cochlear implants market is expected to grow at the fastest rate in the Asia Pacific region. The demand for cochlear implants in the APAC is mainly driven by the growing geriatric population, the increasing GDP of Asian countries, the rising healthcare expenditure in the APAC countries, and growing public awareness. The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30% • By Designation: C-level - 27%, D-level - 18%, and Others - 55% • By Region: North America – 35%, Europe – 31%, Asia Pacific – 22%, Latin America – 9%, Middle East & Africa – 2%, and the GCC Countries – 1% Lists of Companies Profiled in the Report: Cochlear Ltd. (Australia), Sonova (Switzerland), MED-EL Medical Electronics (Austria), Zhejiang Nurotron Biotechnology Co., Ltd. (China), Neubio AG (Switzerland), TODOC Co., Ltd. (South Korea), and Shanghai Listent Medical Tech Co., Ltd. (China). Research Coverage: In this report, the cochlear implants market has been categorized based on type of implants (unilateral implants, bilateral implants), end user (hospitals, ENT clinics, and other end users), patient type (adults, pediatrics), component type (cochlear implant systems, upgrades & accessories), and region (Europe, Middle East & Africa, North America, Latin America, Asia Pacific, and the GCC Countries). Comprehensive information regarding the main drivers, barriers, opportunities, and challenges influencing the cochlear implants market's expansion is included in detail in this study. An exhaustive study of the key players in the cochlear implants market has been done to provide insights into their business profile, products offered, noteworthy strategies, product launches and approvals, and other recent activities pertaining to the market. Reasons to buy this report: The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall cochlear implants market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restaints. The report provides insights on the following pointers: • Analysis of key drivers: (Rising prevalence of hearing impairment, growing geriatric population, and comprehensive insurance coverage and favorable reimbursement policies), restraints (High cost of cochlear implants and associated surgeries and surgical risks, procedural complications, and long post-surgery rehabilitation), opportunities (Lucrative growth opportunities in emerging economies, technological innovations in cochlear implants, and integration with digital health platforms), and challenges (Shortage of skilled professionals performing ENT procedures, competition from alternative solutions) influencing the growth of the in cochlear implants market. • Market Development: Comprehensive information about lucrative markets – the report analyses the cochlear implants market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cochlear implants market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Cochlear Ltd. (Australia), Sonova (Switzerland), and MED-EL Medical Electronics (Austria) are among others, in the cochlear implants market strategies.
目錄 Table of Contents
1 INTRODUCTION 22 1.1 STUDY OBJECTIVES 22 1.2 MARKET DEFINITION 22 1.3 STUDY SCOPE 23 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 23 1.3.2 INCLUSIONS & EXCLUSIONS 24 1.3.3 YEARS CONSIDERED 24 1.3.4 CURRENCY CONSIDERED 25 1.4 STAKEHOLDERS 25 2 RESEARCH METHODOLOGY 26 2.1 RESEARCH DATA 26 2.1.1 SECONDARY DATA 27 2.1.1.1 Key sources for secondary data 27 2.1.1.2 Key data from secondary sources 28 2.1.2 PRIMARY DATA 28 2.1.2.1 Key primary sources 29 2.1.2.2 Objectives of primary research 29 2.1.2.3 Key data from primary sources 30 2.1.2.4 Key industry insights 31 2.1.2.5 Breakdown of primaries 31 2.2 MARKET SIZE ESTIMATION 32 2.2.1 BOTTOM-UP APPROACH 32 2.2.1.1 Company revenue estimation approach 33 2.2.1.1.1 Presentations of companies and primary interviews 33 2.2.1.1.2 Primary interviews 34 2.2.1.1.3 Country-based approach for estimating global market size 34 2.2.1.1.4 Approach for estimating global market size based on units sold 35 2.2.2 TOP-DOWN APPROACH 37 2.3 DATA TRIANGULATION 38 2.4 MARKET SHARE ANALYSIS 39 2.5 STUDY ASSUMPTIONS 39 2.5.1 MARKET ASSUMPTIONS 39 2.5.2 GROWTH RATE ASSUMPTIONS 39 2.6 RESEARCH LIMITATIONS 40 2.6.1 METHODOLOGY-RELATED LIMITATIONS 40 2.6.2 SCOPE-RELATED LIMITATIONS 40   2.7 RISK ASSESSMENT 40 3 EXECUTIVE SUMMARY 41 4 PREMIUM INSIGHTS 45 4.1 COCHLEAR IMPLANTS MARKET OVERVIEW 45 4.2 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE AND COUNTRY (2023) 46 4.3 COCHLEAR IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47 4.4 COCHLEAR IMPLANTS MARKET: REGIONAL MIX (2024–2030) 48 4.5 COCHLEAR IMPLANTS MARKET: DEVELOPED VS. EMERGING ECONOMIES 49 5 MARKET OVERVIEW 50 5.1 INTRODUCTION 50 5.2 MARKET DYNAMICS 50 5.2.1 DRIVERS 50 5.2.1.1 Rising prevalence of hearing impairment 50 5.2.1.2 Growing geriatric population 51 5.2.1.3 Comprehensive insurance coverage and favorable reimbursement policies 52 5.2.2 RESTRAINTS 53 5.2.2.1 High cost of cochlear implants and associated surgeries 53 5.2.2.2 Surgical risks, procedural complications, and long post-surgery rehabilitation 54 5.2.3 OPPORTUNITIES 55 5.2.3.1 Lucrative growth opportunities in emerging economies 55 5.2.3.2 Technological innovations in cochlear implants 56 5.2.3.3 Integration with digital health platforms 56 5.2.4 CHALLENGES 57 5.2.4.1 Shortage of skilled professionals performing ENT procedures 57 5.2.4.2 Competition from alternative solutions 58 5.3 PRICING ANALYSIS 58 5.3.1 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021–2023 58 5.3.2 AVERAGE SELLING PRICE TREND COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021–2023 59 5.4 VALUE CHAIN ANALYSIS 61 5.5 SUPPLY CHAIN ANALYSIS 62 5.6 ECOSYSTEM ANALYSIS 63 5.6.1 ROLE IN ECOSYSTEM 64 5.7 PORTER’S FIVE FORCES ANALYSIS 65 5.7.1 THREAT OF NEW ENTRANTS 66 5.7.2 THREAT OF SUBSTITUTES 66 5.7.3 BARGAINING POWER OF BUYERS 66 5.7.4 BARGAINING POWER OF SUPPLIERS 66 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 67 5.8 KEY STAKEHOLDERS & BUYING CRITERIA 67 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 67 5.8.2 KEY BUYING CRITERIA 68 5.9 REGULATORY ANALYSIS 68 5.9.1 REGULATORY FRAMEWORK 68 5.9.1.1 North America 68 5.9.1.1.1 US 68 5.9.1.1.2 Canada 70 5.9.1.2 Europe 70 5.9.1.3 Asia Pacific 71 5.9.1.3.1 Japan 71 5.9.1.3.2 China 71 5.9.1.3.3 India 72 5.9.1.4 Latin America 72 5.9.1.4.1 Brazil 72 5.9.1.4.2 Mexico 73 5.9.1.5 Middle East 73 5.9.1.6 Africa 73 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 5.10 TRADE ANALYSIS 75 5.10.1 IMPORT DATA FOR HS CODE 902140 75 5.10.2 EXPORT DATA FOR HS CODE 902140 76 5.11 PATENT ANALYSIS 77 5.11.1 LIST OF MAJOR PATENTS 78 5.12 KEY CONFERENCES & EVENTS, 2025–2026 79 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81 5.14 TECHNOLOGY ANALYSIS 81 5.14.1 KEY TECHNOLOGIES 81 5.14.1.1 Electrode-based auditory nerve stimulation 81 5.14.2 COMPLEMENTARY TECHNOLOGIES 82 5.14.2.1 Bimodal hearing solutions 82 5.14.3 ADJACENT TECHNOLOGIES 82 5.14.3.1 Bone conduction hearing devices 82 5.15 INVESTMENT & FUNDING SCENARIO 82 5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET 83   6 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE 84 6.1 INTRODUCTION 85 6.2 COCHLEAR IMPLANT SYSTEMS 85 6.2.1 INCREASED GERIATRIC POPULATION AND AVAILABILITY OF MEDICAL INSURANCE TO BOOST MARKET GROWTH 85 6.3 UPGRADES & ACCESSORIES 89 6.3.1 FOCUS ON TECHNOLOGICAL INNOVATIONS AND DEVICE PERSONALIZATION TO PROPEL MARKET GROWTH 89 7 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT 93 7.1 INTRODUCTION 94 7.2 UNILATERAL IMPLANTS 94 7.2.1 BETTER INSURANCE COVERAGE TO AID ADOPTION OF UNILATERAL IMPLANTS IN PATIENTS 94 7.3 BILATERAL IMPLANTS 97 7.3.1 IMPROVED SOUND LOCALIZATION AND SPEECH COMPREHENSION IN NOISY ENVIRONMENTS AMONG CHILDREN TO AUGMENT GROWTH 97 8 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE 101 8.1 INTRODUCTION 102 8.2 ADULTS 102 8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS IN GERIATRIC POPULATION TO FUEL ADOPTION OF COCHLEAR IMPLANTS 102 8.3 PEDIATRICS 105 8.3.1 EARLY DIAGNOSIS OF HEARING IMPAIRMENTS THROUGH NEWBORN SCREENING PROGRAMS TO SUPPORT MARKET GROWTH 105 9 COCHLEAR IMPLANTS MARKET, BY END USER 110 9.1 INTRODUCTION 111 9.2 HOSPITALS 111 9.2.1 INCREASED ACCESS TO ADVANCED DIAGNOSTIC EQUIPMENT AND PRESENCE OF SKILLED SURGICAL TEAMS TO AID MARKET GROWTH 111 9.3 ENT CLINICS 114 9.3.1 INCREASING AWARENESS OF ENT-RELATED ISSUES AND GROWING NETWORK OF ADVANCED CLINICS TO AID GROWTH 114 9.4 OTHER END USERS 117 10 COCHLEAR IMPLANTS MARKET, BY REGION 121 10.1 INTRODUCTION 122 10.2 NORTH AMERICA 123 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 123 10.2.2 US 126 10.2.2.1 US to dominate North American cochlear implants market during study period 126   10.2.3 CANADA 129 10.2.3.1 Growing geriatric population and rising government health expenditure to propel market growth 129 10.3 EUROPE 132 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 132 10.3.2 GERMANY 135 10.3.2.1 High incidence of hearing impairment and favorable government health insurance schemes to augment growth 135 10.3.3 UK 137 10.3.3.1 Increased prevalence of hearing problems among older adults to boost market growth 137 10.3.4 FRANCE 139 10.3.4.1 Need for advanced treatment options and high government healthcare expenditure to spur market adoption 139 10.3.5 ITALY 141 10.3.5.1 Well-developed healthcare system with high financial resources to fuel uptake of cochlear implants 141 10.3.6 SPAIN 143 10.3.6.1 Long waiting times for ENT appointments and lack of reimbursement to limit market growth 143 10.3.7 REST OF EUROPE 145 10.4 ASIA PACIFIC 148 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 148 10.4.2 JAPAN 151 10.4.2.1 Advanced healthcare system and rapidly growing geriatric population to support market growth 151 10.4.3 CHINA 154 10.4.3.1 Modernization of healthcare facilities and increased patient pool to drive market 154 10.4.4 INDIA 156 10.4.4.1 Higher incidence of hearing impairment and increased government funds to propel market growth 156 10.4.5 AUSTRALIA 158 10.4.5.1 Increasing number of ENT specialists and rising government funding in public hospitals to support market growth 158 10.4.6 REST OF ASIA PACIFIC 161 10.5 LATIN AMERICA 163 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 163 10.5.2 BRAZIL 166 10.5.2.1 Favorable investment scenario from medical device manufacturers to favor market growth 166 10.5.3 MEXICO 168 10.5.3.1 Increased FDI and growing presence of key healthcare companies to support market growth 168 10.5.4 REST OF LATIN AMERICA 170   10.6 MIDDLE EAST & AFRICA 172 10.6.1 FOCUS ON HEALTHCARE SYSTEM MODERNIZATION AND INCREASED GOVERNMENT AWARENESS TO DRIVE MARKET 172 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 173 10.7 GCC COUNTRIES 175 10.7.1 EMPHASIS ON INFRASTRUCTURAL DEVELOPMENT AND HEALTHCARE ACCESS TO SUPPORT MARKET GROWTH 175 10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 176 11 COMPETITIVE LANDSCAPE 178 11.1 INTRODUCTION 178 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN COCHLEAR IMPLANTS MARKET 178 11.3 REVENUE ANALYSIS, 2021–2023 180 11.4 MARKET SHARE ANALYSIS, 2023 181 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 183 11.5.1 STARS 183 11.5.2 EMERGING LEADERS 183 11.5.3 PERVASIVE PLAYERS 183 11.5.4 PARTICIPANTS 183 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 185 11.5.5.1 Company footprint 185 11.5.5.2 Region footprint 185 11.5.5.3 Component type footprint 186 11.5.5.4 Patient type footprint 186 11.5.5.5 End-user footprint 187 11.6 COMPANY VALUATION & FINANCIAL METRICS 187 11.7 BRAND/PRODUCT COMPARISON 188 11.8 COMPETITIVE SCENARIO 189 11.8.1 PRODUCT LAUNCHES & APPROVALS 189 11.8.2 DEALS 190 11.8.3 OTHER DEVELOPMENTS 190 12 COMPANY PROFILES 191 12.1 KEY PLAYERS 191 12.1.1 COCHLEAR LTD. 191 12.1.1.1 Business overview 191 12.1.1.2 Products offered 192 12.1.1.3 Recent developments 194 12.1.1.3.1 Product launches & approvals 194 12.1.1.3.2 Deals 194 12.1.1.4 MnM view 195 12.1.1.4.1 Key strengths 195 12.1.1.4.2 Strategic choices 195 12.1.1.4.3 Weaknesses & competitive threats 195 12.1.2 SONOVA 196 12.1.2.1 Business overview 196 12.1.2.2 Products offered 198 12.1.2.3 Recent developments 198 12.1.2.3.1 Other developments 198 12.1.2.4 MnM view 199 12.1.2.4.1 Key strengths 199 12.1.2.4.2 Strategic choices 199 12.1.2.4.3 Weaknesses & competitive threats 199 12.1.3 MED-EL MEDICAL ELECTRONICS 200 12.1.3.1 Business overview 200 12.1.3.2 Products offered 200 12.1.3.3 Recent developments 201 12.1.3.3.1 Product launches 201 12.1.3.3.2 Deals 201 12.1.3.3.3 Other developments 202 12.1.3.4 MnM view 202 12.1.3.4.1 Key strengths 202 12.1.3.4.2 Strategic choices 202 12.1.3.4.3 Weaknesses & competitive threats 202 12.1.4 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD. 203 12.1.4.1 Business overview 203 12.1.4.2 Products offered 203 12.1.5 NEUBIO AG 205 12.1.5.1 Business overview 205 12.1.5.2 Products offered 205 12.1.6 TODOC CO., LTD. 206 12.1.6.1 Business overview 206 12.1.6.2 Products offered 206 12.1.7 SHANGHAI LISTENT MEDICAL TECH CO., LTD. 207 12.1.7.1 Business overview 207 12.1.7.2 Products offered 207 13 APPENDIX 208 13.1 DISCUSSION GUIDE 208 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 212 13.3 CUSTOMIZATION OPTIONS 214 13.4 RELATED REPORTS 214 13.5 AUTHOR DETAILS 215
圖表清單 List of Tables & Figures
TABLE 1 COCHLEAR IMPLANTS MARKET: INCLUSIONS & EXCLUSIONS 24 TABLE 2 COCHLEAR IMPLANTS MARKET: KEY DATA FROM PRIMARY SOURCES 30 TABLE 3 COCHLEAR IMPLANTS MARKET: MARKET ASSUMPTIONS 39 TABLE 4 COCHLEAR IMPLANTS MARKET: RISK ASSESSMENT 40 TABLE 5 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2023 VS. 2030 VS. 2050 52 TABLE 6 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021–2023 59 TABLE 7 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021–2023 60 TABLE 8 COCHLEAR IMPLANTS MARKET: ROLE IN ECOSYSTEM 64 TABLE 9 COCHLEAR IMPLANTS MARKET: PORTER’S FIVE FORCES 65 TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%) 67 TABLE 11 KEY BUYING CRITERIA FOR MAJOR END USERS 68 TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 69 TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69 TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 70 TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 71 TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES 72 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 22 IMPORT DATA FOR HS CODE 902140, BY COUNTRY, 2019–2023 (USD THOUSAND) 75 TABLE 23 EXPORT DATA FOR HS CODE 902140, BY COUNTRY, 2019–2023 (USD THOUSAND) 76 TABLE 24 COCHLEAR IMPLANTS MARKET: LIST OF MAJOR PATENTS 78 TABLE 25 COCHLEAR IMPLANTS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 79 TABLE 26 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 85 TABLE 27 KEY COCHLEAR IMPLANT SYSTEMS AVAILABLE IN MARKET 86 TABLE 28 COCHLEAR IMPLANT SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION) 87 TABLE 29 NORTH AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 87 TABLE 30 EUROPE: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 88 TABLE 31 ASIA PACIFIC: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 88 TABLE 32 LATIN AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 89 TABLE 33 KEY COCHLEAR IMPLANT UPGRADES & ACCESSORIES AVAILABLE IN MARKET 90 TABLE 34 COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY REGION, 2022–2030 (USD MILLION) 90 TABLE 35 NORTH AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 91 TABLE 36 EUROPE: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 91 TABLE 37 ASIA PACIFIC: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 92 TABLE 38 LATIN AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 92 TABLE 39 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 94 TABLE 40 COCHLEAR UNILATERAL IMPLANTS MARKET, BY REGION, 2022–2030 (USD MILLION) 95 TABLE 41 NORTH AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 95 TABLE 42 EUROPE: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 96 TABLE 43 ASIA PACIFIC: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 96 TABLE 44 LATIN AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 97 TABLE 45 COCHLEAR BILATERAL IMPLANTS MARKET, BY REGION, 2022–2030 (USD MILLION) 98 TABLE 46 NORTH AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98 TABLE 47 EUROPE: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 99 TABLE 48 ASIA PACIFIC: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 99 TABLE 49 LATIN AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 100 TABLE 50 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 102 TABLE 51 COCHLEAR IMPLANTS MARKET FOR ADULTS, BY REGION, 2022–2030 (USD MILLION) 103 TABLE 52 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 53 EUROPE: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 54 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION) 105 TABLE 55 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION) 105 TABLE 56 COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY REGION, 2022–2030 (USD MILLION) 107 TABLE 57 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION) 107 TABLE 58 EUROPE: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION) 108 TABLE 59 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION) 108 TABLE 60 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION) 109 TABLE 61 COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 111 TABLE 62 COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION) 112 TABLE 63 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 113 TABLE 64 EUROPE: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 113 TABLE 65 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 114 TABLE 66 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION) 114 TABLE 67 COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY REGION, 2022–2030 (USD MILLION) 115 TABLE 68 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 115 TABLE 69 EUROPE: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 116 TABLE 70 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 116 TABLE 71 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 117 TABLE 72 COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 118 TABLE 73 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 118 TABLE 74 EUROPE: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 119 TABLE 75 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 119 TABLE 76 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 120 TABLE 77 HEARING AIDS SOLD GLOBALLY, 2022–2030 (MILLION UNITS) 122 TABLE 78 COCHLEAR IMPLANTS MARKET, BY REGION, 2022–2030 (USD MILLION) 122 TABLE 79 NORTH AMERICA: MACROECONOMIC INDICATORS 124 TABLE 80 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 125 TABLE 81 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 125 TABLE 82 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 125 TABLE 83 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030(USD MILLION) 126 TABLE 84 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 126 TABLE 85 US: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 128 TABLE 86 US: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 128 TABLE 87 US: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 129 TABLE 88 US: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 129 TABLE 89 CANADA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 131 TABLE 90 CANADA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 131 TABLE 91 CANADA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 131 TABLE 92 CANADA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 132 TABLE 93 EUROPE: MACROECONOMIC INDICATORS 133 TABLE 94 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 133 TABLE 95 EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 133 TABLE 96 EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 134 TABLE 97 EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 134 TABLE 98 EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 134 TABLE 99 GERMANY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 136 TABLE 100 GERMANY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 136 TABLE 101 GERMANY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 136 TABLE 102 GERMANY: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 137 TABLE 103 UK: NUMBER OF NEW COCHLEAR IMPLANT RECIPIENTS 138 TABLE 104 UK: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 138 TABLE 105 UK: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 138 TABLE 106 UK: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 139 TABLE 107 UK: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 139 TABLE 108 FRANCE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 140 TABLE 109 FRANCE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 140 TABLE 110 FRANCE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 141 TABLE 111 FRANCE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 141 TABLE 112 ITALY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 142 TABLE 113 ITALY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 142 TABLE 114 ITALY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 143 TABLE 115 ITALY: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 143 TABLE 116 SPAIN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 144 TABLE 117 SPAIN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 144 TABLE 118 SPAIN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 145 TABLE 119 SPAIN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 145 TABLE 120 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 146 TABLE 121 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 146 TABLE 122 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 147 TABLE 123 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 147 TABLE 124 ASIA PACIFIC: MACROECONOMIC INDICATORS 148 TABLE 125 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 150 TABLE 126 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 150 TABLE 127 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 150 TABLE 128 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 151 TABLE 129 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 151 TABLE 130 JAPAN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 152 TABLE 131 JAPAN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 153 TABLE 132 JAPAN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 153 TABLE 133 JAPAN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 153 TABLE 134 CHINA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 154 TABLE 135 CHINA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 155 TABLE 136 CHINA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 155 TABLE 137 CHINA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 155 TABLE 138 INDIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 157 TABLE 139 INDIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 157 TABLE 140 INDIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 158 TABLE 141 INDIA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 158 TABLE 142 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 159 TABLE 143 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 160 TABLE 144 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 160 TABLE 145 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 160 TABLE 146 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 162 TABLE 147 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 162 TABLE 148 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 162 TABLE 149 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 163 TABLE 150 LATIN AMERICA: MACROECONOMIC INDICATORS 164 TABLE 151 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 164 TABLE 152 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 164 TABLE 153 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 165 TABLE 154 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 165 TABLE 155 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 165 TABLE 156 BRAZIL: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 166 TABLE 157 BRAZIL: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 167 TABLE 158 BRAZIL: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 167 TABLE 159 BRAZIL: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 167 TABLE 160 MEXICO: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 168 TABLE 161 MEXICO: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 169 TABLE 162 MEXICO: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 169 TABLE 163 MEXICO: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 169 TABLE 164 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 170 TABLE 165 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 171 TABLE 166 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 171 TABLE 167 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 171 TABLE 168 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 173 TABLE 169 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 173 TABLE 170 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 174 TABLE 171 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 174 TABLE 172 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 174 TABLE 173 GCC COUNTRIES: MACROECONOMIC INDICATORS 176 TABLE 174 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION) 176 TABLE 175 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION) 176 TABLE 176 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION) 177 TABLE 177 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION) 177 TABLE 178 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS IN COCHLEAR IMPLANTS MARKET 178 TABLE 179 COCHLEAR IMPLANTS MARKET: DEGREE OF COMPETITION 181 TABLE 180 COCHLEAR IMPLANTS MARKET: REGION FOOTPRINT 185 TABLE 181 COCHLEAR IMPLANTS MARKET: COMPONENT TYPE FOOTPRINT 186 TABLE 182 COCHLEAR IMPLANTS MARKET: PATIENT TYPE FOOTPRINT 186 TABLE 183 COCHLEAR IMPLANTS MARKET: END-USER FOOTPRINT 187 TABLE 184 COCHLEAR IMPLANTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 189 TABLE 185 COCHLEAR IMPLANTS MARKET: DEALS, JANUARY 2021–DECEMBER 2024 190 TABLE 186 COCHLEAR IMPLANTS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 190 TABLE 187 COCHLEAR LTD.: COMPANY OVERVIEW 191 TABLE 188 COCHLEAR LTD.: PRODUCTS OFFERED 192 TABLE 189 COCHLEAR LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024 194 TABLE 190 COCHLEAR LTD.: DEALS, JANUARY 2021–DECEMBER 2024 194 TABLE 191 SONOVA: COMPANY OVERVIEW 196 TABLE 192 EXCHANGE RATES USED FOR CONVERSION OF CHF TO USD 197 TABLE 193 SONOVA: PRODUCTS OFFERED 198 TABLE 194 SONOVA: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 198 TABLE 195 MED-EL MEDICAL ELECTRONICS: COMPANY OVERVIEW 200 TABLE 196 MED-EL MEDICAL ELECTRONICS: PRODUCTS OFFERED 200 TABLE 197 MED-EL MEDICAL ELECTRONICS: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024 201 TABLE 198 MED-EL MEDICAL ELECTRONICS: DEALS, JANUARY 2021–DECEMBER 2024 201 TABLE 199 MED-EL MEDICAL ELECTRONICS: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 202 TABLE 200 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 203 TABLE 201 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 203 TABLE 202 NEUBIO AG: COMPANY OVERVIEW 205 TABLE 203 NEUBIO AG: PRODUCTS OFFERED 205 TABLE 204 TODOC CO., LTD.: COMPANY OVERVIEW 206 TABLE 205 TODOC CO., LTD.: PRODUCTS OFFERED 206 TABLE 206 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: COMPANY OVERVIEW 207 TABLE 207 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: PRODUCTS OFFERED 207 _ FIGURE 1 COCHLEAR IMPLANTS MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 23 FIGURE 2 COCHLEAR IMPLANTS MARKET: YEARS CONSIDERED 24 FIGURE 3 COCHLEAR IMPLANTS MARKET: RESEARCH DESIGN 26 FIGURE 4 COCHLEAR IMPLANTS MARKET: KEY DATA FROM SECONDARY SOURCES 28 FIGURE 5 COCHLEAR IMPLANTS MARKET: KEY PRIMARY SOURCES 29 FIGURE 6 COCHLEAR IMPLANTS MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 31 FIGURE 7 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 31 FIGURE 8 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 32 FIGURE 9 COCHLEAR IMPLANTS MARKET: REVENUE SHARE ANALYSIS 33 FIGURE 10 COUNTRY-BASED APPROACH FOR ESTIMATING GLOBAL MARKET SIZE 34 FIGURE 11 COCHLEAR IMPLANTS MARKET: APPROACH FOR ESTIMATING GLOBAL MARKET SIZE BASED ON UNITS SOLD 35 FIGURE 12 COCHLEAR IMPLANTS MARKET: CAGR PROJECTIONS (SUPPLY SIDE) 36 FIGURE 13 COCHLEAR IMPLANTS MARKET: TOP-DOWN APPROACH 37 FIGURE 14 COCHLEAR IMPLANTS MARKET: DATA TRIANGULATION 38 FIGURE 15 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2024 VS. 2030 (USD MILLION) 41 FIGURE 16 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2024 VS. 2030 (USD MILLION) 42 FIGURE 17 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2024 VS. 2030 (USD MILLION) 42 FIGURE 18 COCHLEAR IMPLANTS MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 43 FIGURE 19 COCHLEAR IMPLANTS MARKET: REGIONAL SNAPSHOT 44 FIGURE 20 INCREASING PATIENT POOL AND RISING HEALTHCARE EXPENDITURE TO DRIVE MARKET 45 FIGURE 21 US AND COCHLEAR IMPLANT SYSTEMS COMMANDED LARGEST MARKET SHARE IN 2023 46 FIGURE 22 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030 47 FIGURE 23 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING STUDY PERIOD 48 FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 49 FIGURE 25 COCHLEAR IMPLANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50 FIGURE 26 COCHLEAR IMPLANTS MARKET: VALUE CHAIN ANALYSIS 61 FIGURE 27 COCHLEAR IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS 62 FIGURE 28 COCHLEAR IMPLANTS MARKET: ECOSYSTEM ANALYSIS 63 FIGURE 29 KEY PLAYERS IN COCHLEAR IMPLANTS MARKET ECOSYSTEM 63 FIGURE 30 COCHLEAR IMPLANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 65 FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 67 FIGURE 32 KEY BUYING CRITERIA FOR MAJOR END USERS 68 FIGURE 33 PATENT ANALYSIS FOR COCHLEAR IMPLANTS, JANUARY 2014–DECEMBER 2024 77 FIGURE 34 COCHLEAR IMPLANTS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81 FIGURE 35 COCHLEAR IMPLANTS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024 82 FIGURE 36 NORTH AMERICA: COCHLEAR IMPLANTS MARKET SNAPSHOT 124 FIGURE 37 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET SNAPSHOT 149 FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET, 2021–2023 180 FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET (2023) 181 FIGURE 40 COCHLEAR IMPLANTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 184 FIGURE 41 COCHLEAR IMPLANTS MARKET: COMPANY FOOTPRINT 185 FIGURE 42 EV/EBITDA OF KEY VENDORS 187 FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 188 FIGURE 44 COCHLEAR IMPLANTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 188 FIGURE 45 COCHLEAR LTD.: COMPANY SNAPSHOT 192 FIGURE 46 SONOVA: COMPANY SNAPSHOT 197

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們